PharmiWeb.com - Global Pharma News & Resources
17-Jan-2019

Cancer Immunotherapy Market to Gain US$124.88 Billion by 2024, Says TMR

Cancer Immunotherapy Market to Gain US$124.88 Billion by 2024, Says TMR

PR Newswire

ALBANY, New York, January 17, 2019

ALBANY, New York, January 17, 2019 /PRNewswire/ --

According to TMR, over the forecast period of 2016 to 2024, the global cancer immunotherapy market is expected to rise at a 14.5% CAGR. The market was estimated to be at US$37.50 bn in 2015, and is projected to reach US$124.88 bn by 2024.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Surge in Incidence of Malignancy to Boost Growth 

14.1 million new cases of cancer have been worldwide diagnosed in 2012 according to GLOBOCAN. In the next two decades, the growth of incidence of cancer in the next 22 million case studies is expected to increase by 70 percent. In lower and middle income countries, cancer is widely prevalent as there is a lack of adequate health infrastructures to combat the condition effectively. Similarly, in less-developed regions, 65 percent of total worldwide cancer deaths were reported. Another key factor contributing to the growth is the increased adoption of cancer immunotherapy in other conventional treatments due to increased survival rate and less side effects of immunotherapy drugs.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4312

Emergence of Bioinformatics to Remain Key Market Trend 

Cancer bioinformatics is a leading industry in medicines and clinical applications in the field of omics. Bioinformatics are now not omnipotent, like other biological techniques or systems. Bioinformatics studies will be important in the drug development process as the therapeutic field of immune control inhibitors mature. Bioinformatics analysis can provide insights into the working of current therapeutics and identify the gaps that future generations of therapies need to address. The implementation of efficient and replicable bioinformatics pipelines will be crucial to success as the cancer immunotherapy field continues. This is expected to be a key trend that will be accessible for vendors to capitalize on and grow in the cancer immunotherapy market.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4312

The global cancer immunotherapy market is prognosticated to see a positive growth curve in the forthcoming years, as reported by Transparency Market Research (TMR). The global cancer immunotherapy market's competitive landscape is currently a fragmented one. Several small-scaled and large-scaled companies exist in the market, fostering healthy competition. A key point of rivalry among the vendors is the entry of novel drugs. Prominent vendors in the global cancer immunotherapy market are focusing on research and development in order to introduce innovative drugs. A prime example is the emergence of drugs with antibody dependent cellular toxicity. This is a key trend being capitalized on by vendors in the global cancer immunotherapy market in order to gain traction.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4312

Vendors in the global cancer immunotherapy market are further adopting strategies such as mergers and acquisitions, and ensuring a differentiated product portfolio, to gain momentum in the industry. The brisk uptake of advanced treatment options, and improved healthcare is likely to boost opportunity for players in the cancer immunotherapy market in the coming years.

Prominent vendors in the global cancer immunotherapy market are Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., AstraZeneca Plc., and GlaxoSmithKline Plc.

Browse Press Release - https://www.transparencymarketresearch.com/pressrelease/cancer-immunotherapy-market.htm

The study presented here is based on a report by Transparency Market Research (TMR) titled, "Cancer Immunotherapy Market (Therapy Type - Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines; Therapeutic Areas - Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Melanoma, and Blood Cancers; End Users - Hospitals, ASC's (Ambulatory Surgical Centers), and Cancer Research Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."

Popular Research Reports by TMR: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Research Blog: https://theglobalhealthnews.com/

SOURCE Transparency Market Research

Editor Details

Last Updated: 17-Jan-2019